BMO Capital raised the firm’s price target on Kinaxis to C$185 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on KXSCF: Kinaxis downgraded to Neutral from Outperformer at CIBC Kinaxis Shareholders Approve All Resolutions Kinaxis initiated with a Buy at Redburn Atlantic Kinaxis Reports Strong Q1 Growth, Raises Profit Outlook Disclaimer & DisclosureReport an Issue